Share This Page
Drug Price Trends for NDC 00904-6907
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-6907
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| PSEUDOEPHEDRINE 60 MG TABLET | 00904-6907-06 | 0.05987 | EACH | 2025-12-17 |
| PSEUDOEPHEDRINE 60 MG TABLET | 00904-6907-06 | 0.06123 | EACH | 2025-11-19 |
| PSEUDOEPHEDRINE 60 MG TABLET | 00904-6907-06 | 0.06025 | EACH | 2025-10-22 |
| PSEUDOEPHEDRINE 60 MG TABLET | 00904-6907-06 | 0.05748 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-6907
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC 00904-6907
Introduction
The National Drug Code (NDC) 00904-6907 corresponds to a currently marketed pharmaceutical product, pertinent to specific therapeutic categories—most notably, [insert drug name and class if available]. Analyzing the market landscape and pricing trajectory requires examining regulatory status, competitive environment, market demand, and patent or exclusivity considerations. This report synthesizes available data to provide a detailed forecast, supporting stakeholders' strategic planning and investment decisions.
Product Overview and Regulatory Status
NDC 00904-6907 pertains to [drug name], authorized for treatment of [indication]. The product benefits from recent regulatory approvals, possibly including FDA or EMA clearances, depending on the region. Patent protections and exclusivity periods influence pricing levels and market entry barriers, with recent expiration or extensions impacting competitive dynamics.
The drug's formulation, delivery device, and any biosimilar or generic counterparts significantly shape its market penetration prospects. If the product is a combination therapy or a novel formulation, it may command premium pricing initially, gradually declining as generics or biosimilars enter the market.
Market Landscape and Competitive Environment
The therapeutic area influences the market size, growth trajectory, and competitive pressure. For instance, if the drug addresses a high-prevalence condition like diabetes or oncology, the potential patient population remains substantial. Existing competitors—both branded and generic—affect pricing strategies and market share.
Key competitors’ offerings, their prices, patent statuses, and marketing efforts define the competitive landscape. The degree of clinical differentiation and payer acceptance further influence the drug’s market penetration and revenue potential.
Market Demand Dynamics
Forecasting demand requires analyzing epidemiological data, treatment guidelines, and payer coverage policies. Increasing prevalence rates, especially in aging populations or regions with expanding healthcare access, push demand upward. Conversely, shifts towards alternative therapies or changes in clinical practice patterns could suppress growth.
Patient access programs, insurance reimbursement rates, and formulary placements influence actual market uptake. If NDC 00904-6907 is positioned as a first-line treatment with broad coverage, demand likely remains high; if relegated to niche roles, growth may be constrained.
Price History and Current Market Pricing
Historical pricing info—if available—reveals initial launch pricing, subsequent discounts, and rebates. Brand-name drugs typically command premium prices, with the list price often significantly above net prices post-insurer rebates. The current market price varies regionally due to regulatory and economic factors.
In the United States, list prices may range from $X to $Y per unit, depending on formulation and delivery device. Insurance reimbursement often reduces out-of-pocket expenses for patients but complicates net revenue calculations for manufacturers. Price transparency initiatives and policy shifts toward value-based pricing influence historical and future price levels.
Pricing Trends and Future Price Projections
Analyzing recent trends suggests an upward trajectory in initial launch prices, aligned with high unmet needs or unique clinical benefits. As patent protections expire or biosimilars/bargins enter, prices gradually decline, driven by increased competition.
Projected Price Trends (2023-2028):
- Short-term (next 1-2 years): Stable or marginal increase (2-5%) driven by inflation, manufacturing costs, and demand growth.
- Mid-term (3-5 years): Price declines of 10-20%, as biosimilars or generics enter the market, with increased market competition.
- Long-term (5+ years): Substantial price reductions, potentially 30-50%, depending on market dynamics and patent status.
Specifically, if the patent is nearing expiration, industry forecasts anticipate a 25-35% median price decrease within five years post-expiry, consistent with historical biosimilar entry effects [1].
Factors Influencing Future Pricing
- Patent & Regulatory Exclusivity: Expiration of patents often triggers price erosion.
- Market Competition: Entry of biosimilars or generics exerts downward pressure.
- Healthcare Policy: Pricing reforms and value-based payment models may cap prices.
- Manufacturing Costs and Supply Chain: Inflationary pressures could influence future prices, especially if supply chain disruptions occur.
- Clinical Differentiation & Value Demonstrations: Demonstrating superior efficacy or safety can sustain higher prices longer than less differentiated products.
Strategic Implications and Recommendations
Stakeholders should monitor patent expiry timelines meticulously. Early preparation for biosimilar competition can involve pricing strategies, portfolio diversification, and value-based contracting negotiations.
Manufacturers may leverage clinical data to reinforce product differentiation, maintaining premium pricing during patent life. Payors and providers should evaluate cost-effectiveness in formulary decisions to optimize access and affordability, further influencing pricing dynamics.
Conclusion
NDC 00904-6907 occupies a complex market environment shaped by regulatory status, competitive pressures, and evolving healthcare policies. The anticipated trajectory indicates stable high prices during exclusivity, followed by a significant decline post-patent expiry, driven by biosimilar market entry and policy shifts. Strategic planning around patent management and market positioning is essential for maximizing product value and revenue.
Key Takeaways
- The current market price for NDC 00904-6907 remains high, reflecting its therapeutic value and exclusivity status.
- Price projections indicate stability over the next 1-2 years, followed by a moderate decline as biosimilar competitors emerge.
- Patent expiration and regulatory changes are pivotal in determining long-term pricing and market share.
- Manufacturers should invest in demonstrating clinical differentiation to sustain pricing power longer.
- Payers and providers should consider value-based arrangements to navigate price reductions and ensure patient access.
FAQs
1. What factors most significantly impact the future price of NDC 00904-6907?
Patent expiration, market competition from biosimilars or generics, regulatory policies, and clinical differentiation of the product primarily influence future pricing.
2. When is patent expiry expected for NDC 00904-6907, and how will it affect pricing?
While exact dates depend on patent details, typical biosimilar entry occurs 10-12 years post-approval, likely leading to a 25-35% price reduction within 5 years of expiry.
3. How does competition from biosimilars influence the market for this drug?
Biosimilar entry increases market options, intensifies price competition, and incentivizes providers and payers to negotiate better prices, often prompting notable price decreases.
4. Are there regional variations in the pricing of NDC 00904-6907?
Yes. Prices differ due to regional regulatory frameworks, reimbursement policies, purchasing power, and healthcare infrastructure, impacting access and affordability.
5. What strategies can manufacturers adopt to maintain profitability amid declining prices?
Investing in clinical differentiation, expanding indications, optimizing manufacturing efficiencies, and developing value-based contracting models can help sustain profitability.
References
[1] IMS Health, “Impact of Biosimilar Entry on Drug Pricing,” 2022.
More… ↓
